CLINICAL_TRIALS trial_result · 2011-08-23

Clinical Trial Update: ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC) [Phase 2]

A Phase 2 trial of RDC-1036 (ALKS 37) in adults with opioid-induced constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alkermes, Inc. | Conditions: Opioid-induced Constipation | Phase 2 | Status: COMPLETED